Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients

Anticancer Res. Sep-Oct 1993;13(5C):1895-900.

Abstract

In breast cancer, axillary lymph node invasiveness is the major prognostic factor in predicting relapse and metastasis. Nevertheless, since 30% of node-negative tumours also relapse, it is necessary to develop other independent prognostic factors. Oncogene amplification and overexpression as well as the level of cathepsin-D have been proposed as additional prognostic factors. Recent studies suggest that the acidic lysosomal proteinase cath-D, present in all cells and known to be secreted in breast cancer cells, may be implicated in the process of tumour invasion and metastasis. We have compared the cytosolic cath-D level with the amplification and the overexpression of the oncogenes c-myc and c-erb-b-2 in 62 breast carcinomas (52 primary and 10 metastatic). Using a cut-off level of 60 pmol/mg protein, the status of cath-D showed a positive correlation with c-myc amplification (P = 0.01) or overexpression (P = 0.02). In contrast, no correlation was found between cath-D and c-erb-B-2 amplification or overexpression. Also, no correlation was found between cath-D and established prognostic factors such as node invasiveness, steroid receptors, grade and menopausal status. Nevertheless, a weak correlation was found between cath-D levels and tumour status (P = 0.05). In conclusion, in breast cancer, a high cytosolic cath-D concentration is more frequent in tumours with c-myc amplification and overexpression but is dissociated from c-erb-B-2 amplification or overexpression, suggesting that the determination of cath-D, as well as the latter two markers, will have an additional prognostic value.

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / pathology
  • Cathepsin D / analysis*
  • Cytosol / chemistry
  • ErbB Receptors / analysis*
  • Female
  • Gene Amplification
  • Genes, myc
  • Humans
  • Immunoradiometric Assay
  • Lymphatic Metastasis
  • Menopause
  • Prognosis
  • Proto-Oncogene Proteins / analysis*
  • Receptor, ErbB-2
  • Receptors, Steroid / analysis

Substances

  • Proto-Oncogene Proteins
  • Receptors, Steroid
  • ErbB Receptors
  • Receptor, ErbB-2
  • Cathepsin D